
Targeted Therapy for KLK2 Prostate Cancer
Abstract: Kallikrein 2(KLK2) is the trypsin-like serine protease, about 78% homologous with prostate-specific antigen(PSA). Androgen receptor(AR) regulated-KLK2 is specifically expressed in prostatic epithelial and cancer cells. KLK2 plays an important role in the development of prostate cancer, and relevant to tumor invasion. Thus, KLK2 is considered to be a potential biomarker for prostate cancer targeted …